APOE, or apolipoprotein E, is a gene closely linked to Alzheimer's disease (AD). It comes in three primary variants: APOE ε2, APOE ε3, and APOE ε4. APOE ε4, in particular, significantly raises the risk of developing late-onset Alzheimer's. Having one copy of APOE ε4 increases susceptibility, while having two copies further heightens this risk. This gene variant influences how the brain processes fats and plays a role in the accumulation and clearance of amyloid-beta plaques, which are characteristic of AD. Researchers are actively exploring how APOE ε4 contributes to Alzheimer's pathology, aiming to develop targeted therapies that address its impact on disease progression.
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Association between APOE allele prevalence and Alzheimer's disease risk in Southwestern Uganda
Frank Balikoowa, African Research Center for Ageing & Dementia, Uganda
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China